{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:08:53Z","timestamp":1790064533909,"version":"4.0.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.mtbio.2026.103121","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T14:59:09Z","timestamp":1776524349000},"page":"103121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Biomaterial-enabled multimodal therapy for endometrial cancer: Subtype-guided immuno-metabolic modulation and fertility-conscious regeneration"],"prefix":"10.1016","volume":"38","author":[{"given":"Min","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benshuo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8444-0508","authenticated-orcid":false,"given":"Chong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.103121_bib1","article-title":"Cancer statistics","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.mtbio.2026.103121_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.mtbio.2026.103121_bib3","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.mtbio.2026.103121_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179274","article-title":"Molecular basis of endometriosis and endometrial cancer: current knowledge and future perspectives","volume":"22","author":"Terzic","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103121_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102790","article-title":"Locally advanced and metastatic endometrial cancer: current and emerging therapies","volume":"129","author":"Salmon","year":"2024","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.mtbio.2026.103121_bib7","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.mtbio.2026.103121_bib8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/cancers16051028","article-title":"Recent advances in endometrial cancer prevention, early diagnosis and treatment","author":"Baker-Rand","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.mtbio.2026.103121_bib9","article-title":"Advances in the management of endometrial cancer","volume":"388","author":"Corr","year":"2025","journal-title":"Bmj"},{"key":"10.1016\/j.mtbio.2026.103121_bib10","first-page":"526","article-title":"Endometrial cancer: rapid evidence review","volume":"111","author":"Bryce","year":"2025","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.mtbio.2026.103121_bib11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/medicina61030471","article-title":"Fertility-sparing treatments in endometrial cancer: a comprehensive review on efficacy, oncological outcomes, and reproductive potential","volume":"61","author":"Ronsini","year":"2025","journal-title":"Medicina"},{"key":"10.1016\/j.mtbio.2026.103121_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105159","article-title":"Endometrial cancer: improving management among increasing incidence rates","volume":"103","author":"eBioMedicine","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mtbio.2026.103121_bib13","first-page":"609","article-title":"Imaging of endometrial cancer","volume":"61","author":"Sbarra","year":"2023","journal-title":"Radiol. Clin."},{"key":"10.1016\/j.mtbio.2026.103121_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/cancers17010112","article-title":"Fertility sparing in endometrial cancer: where are we now?","volume":"17","author":"Centini","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mtbio.2026.103121_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ijgc-2022-003675","article-title":"Immunotherapy in endometrial cancer","volume":"33","author":"Mahdi","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.mtbio.2026.103121_bib16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.annonc.2022.05.519","article-title":"Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study","volume":"33","author":"Maio","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003777","volume":"10","author":"Oaknin","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2026.103121_bib18","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1200\/JCO.22.02152","article-title":"Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: updated efficacy and safety from the randomized phase III Study 309\/KEYNOTE-775","volume":"41","author":"Makker","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1056\/NEJMoa2108330","article-title":"Lenvatinib plus pembrolizumab for advanced endometrial cancer","volume":"386","author":"Makker","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mtbio.2026.103121_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.mtbio.2026.103121_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Disease analysis working, Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Levine","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103121_bib22","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3390\/jcm14041385","article-title":"Comprehensive review of endometrial cancer: new molecular and FIGO classification and recent treatment changes","volume":"14","author":"Anca-Stanciu","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.mtbio.2026.103121_bib23","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.3390\/ijms25115893","article-title":"Molecular classification of endometrial cancer and its impact on therapy selection","volume":"25","author":"Galant","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103121_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1503901","article-title":"Implementation of the ProMisE classifier and validation of its prognostic impact in Brazilian endometrial carcinomas","volume":"14","author":"Andrade","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2022.10.024","article-title":"Molecular testing for endometrial cancer: an SGO clinical practice statement","volume":"168","author":"Walsh","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib26","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.mtbio.2026.103121_bib27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.6004\/jnccn.2022.7096","article-title":"Molecular profiling of endometrial cancer from TCGA to clinical practice","volume":"21","author":"Jamieson","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.mtbio.2026.103121_bib28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ijgo.14969","article-title":"Molecular subtypes of endometrial cancer: implications for adjuvant treatment strategies","volume":"164","author":"Yang","year":"2024","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.mtbio.2026.103121_bib29","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/ijgc-2020-001822","article-title":"Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy","volume":"31","author":"van den Heerik","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.mtbio.2026.103121_bib30","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1126\/science.8134835","article-title":"New challenges in biomaterials","volume":"263","author":"Peppas","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.mtbio.2026.103121_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2025.103074","article-title":"Endometrial regeneration and the role of the extracellular matrix: mechanisms, challenges, and future perspectives","volume":"97","author":"Asadikalameh","year":"2025","journal-title":"Tissue Cell"},{"key":"10.1016\/j.mtbio.2026.103121_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114028","article-title":"Nanocarrier drug delivery systems for gynecological cancer therapeutics","volume":"385","author":"Berezowitz","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103121_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117328","article-title":"Oral nano-formulations for endocrine therapy of endometrioid adenocarcinomas","volume":"179","author":"Cui","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mtbio.2026.103121_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1570011","article-title":"Endocrine therapy for endometrial cancer: traditional approaches and novel targets","volume":"15","author":"Guan","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib35","volume":"35","author":"Valabrega","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.mtbio.2026.103121_bib36","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3390\/pharmaceutics14091908","article-title":"Injectable Hydrogel-Based combination cancer immunotherapy for overcoming localized therapeutic efficacy","volume":"14","author":"Kim","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.103121_bib37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10147-024-02568-2","article-title":"Immunotherapy for endometrial cancer","volume":"30","author":"Wada","year":"2025","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib38","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1158\/1078-0432.CCR-21-1564","article-title":"Facts and hopes in immunotherapy of endometrial cancer","volume":"28","author":"Mar\u00edn-Jim\u00e9nez","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103121_bib39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/14737140.2024.2367472","article-title":"Immunotherapy in MMR-d\/MSI-H recurrent\/metastatic endometrial cancer","volume":"24","author":"Pacholczak-Madej","year":"2024","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.mtbio.2026.103121_bib40","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.annonc.2024.02.006","article-title":"Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer","volume":"35","author":"Bogani","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib41","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.3802\/jgo.2019.30.e46","article-title":"Immunotherapy in endometrial cancer: new scenarios on the horizon","volume":"30","author":"Di Tucci","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.mtbio.2026.103121_bib42","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ygyno.2021.05.026","article-title":"Implementation of the 2021 molecular ESGO\/ESTRO\/ESP risk groups in endometrial cancer","volume":"162","author":"Imboden","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib43","article-title":"Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment","volume":"15","author":"Tashireva","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.103121_bib44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ctrv.2017.07.008","article-title":"Immunotherapy in ovarian, endometrial and cervical cancer: state of the art and future perspectives","volume":"59","author":"Ventriglia","year":"2017","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.mtbio.2026.103121_bib45","article-title":"Biomarkers and immunotherapy in endometrial cancer: mechanisms and clinical applications","volume":"16","author":"Zhao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.103121_bib46","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1002\/cncr.35417","article-title":"Top advances of the year: immunotherapy in endometrial cancer","volume":"130","author":"Banerjee","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.mtbio.2026.103121_bib47","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1200\/JCO.21.01874","article-title":"Pembrolizumab in patients with microsatellite instability-high advanced endometrial cancer: results from the KEYNOTE-158 Study","volume":"40","author":"O'Malley","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib48","first-page":"1030","volume":"13","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mtbio.2026.103121_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911684","article-title":"TCGA molecular prognostic groups of endometrial carcinoma: current knowledge and future perspectives","volume":"23","author":"Arciuolo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103121_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1035616","article-title":"Tumor immune microenvironment in endometrial cancer of different molecular subtypes: evidence from a retrospective observational study","volume":"13","author":"Dai","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.103121_bib51","doi-asserted-by":"crossref","first-page":"29439","DOI":"10.1021\/acsnano.3c12337","article-title":"Robust and sustained STING pathway activation via Hydrogel-Based in situ vaccination for cancer immunotherapy","volume":"18","author":"Cheng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103121_bib52","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1158\/1078-0432.CCR-24-3905","article-title":"Precision endocrine therapy in endometrial cancer: has its time finally come?","volume":"31","author":"Garg","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103121_bib53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ygyno.2018.12.018","article-title":"Endocrine therapy in endometrial cancer: an old dog with new tricks","volume":"153","author":"Jerzak","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib54","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1039\/D4MD00089G","article-title":"Small molecule targeted therapies for endometrial cancer: progress, challenges, and opportunities","volume":"15","author":"Yang","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.mtbio.2026.103121_bib55","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1158\/0008-5472.CAN-23-0694","article-title":"The next-generation oral selective Estrogen receptor degrader Camizestrant (AZD9833) suppresses ER+ breast cancer growth and overcomes endocrine and CDK4\/6 inhibitor resistance","volume":"83","author":"Lawson","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103121_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23027","article-title":"Fucoxanthin prevents cell growth and induces apoptosis in endometrial cancer HEC-1A cells by the inhibition of the PI3K\/Akt\/mTOR pathway","volume":"36","author":"Qu","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.mtbio.2026.103121_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1166948","article-title":"The interplay of sex steroid hormones and microRNAs in endometrial cancer: current understanding and future directions","volume":"14","author":"Thakur","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mtbio.2026.103121_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.872995","article-title":"Metabolic syndrome as a risk factor of endometrial cancer: a nationwide population-based cohort Study of 2.8 million women in South Korea","volume":"12","author":"Jo","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib59","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.3390\/cancers17233840","article-title":"The role of \"Metabolic Instability\" as a new risk criterion in the pathogenesis of endometrial cancer","volume":"17","author":"Sukhanova","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mtbio.2026.103121_bib60","article-title":"Metabolic syndrome and survival outcomes in endometrial cancer","volume":"16","author":"Marin","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.mtbio.2026.103121_bib61","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/curroncol31020075","article-title":"Insulin resistance: the increased risk of cancers","volume":"31","author":"Szablewski","year":"2024","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115348","article-title":"Nanocarrier-based targeting of metabolic pathways for endometrial cancer: status and future perspectives","volume":"166","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mtbio.2026.103121_bib63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-cellbio-011723-021442","article-title":"Mechanisms of regeneration and fibrosis in the endometrium","volume":"39","author":"Ang","year":"2023","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.mtbio.2026.103121_bib64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11154-024-09923-8","article-title":"Role of HOXA10 in pathologies of the endometrium","volume":"26","author":"Mishra","year":"2025","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.mtbio.2026.103121_bib65","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12032-014-0052-2","article-title":"Upregulation HOXA10 homeobox gene in endometrial cancer: role in cell cycle regulation","volume":"31","author":"Zhang","year":"2014","journal-title":"Med. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib66","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/RAF-21-0078","article-title":"Insights from genomic studies on the role of sex steroids in the aetiology of endometriosis","volume":"3","author":"Saunders","year":"2022","journal-title":"Reprod Fertil"},{"key":"10.1016\/j.mtbio.2026.103121_bib67","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s43032-025-01802-0","article-title":"The effect of endometrial polyp and myoma Uteri on fertility-related genes in the endometrium","volume":"32","author":"\u00d6zbey","year":"2025","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.mtbio.2026.103121_bib68","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/JME-22-0051","article-title":"Loss of HOXA10 causes endometrial hyperplasia progressing to endometrial cancer","volume":"69","author":"Mishra","year":"2022","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.mtbio.2026.103121_bib69","doi-asserted-by":"crossref","DOI":"10.1530\/REP-24-0019","article-title":"Impaired fertility in adenomyosis: a murine model reveals endometrial receptivity and progesterone resistance imbalances","volume":"167","author":"Squatrito","year":"2024","journal-title":"Reproduction"},{"key":"10.1016\/j.mtbio.2026.103121_bib70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12957-023-02893-2","article-title":"Expression of EMT-related genes in lymph node metastasis in endometrial cancer: a TCGA-based study","volume":"21","author":"Li","year":"2023","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib71","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/CEJ.0000000000000965","article-title":"Endometriosis and cancer risk","volume":"34","author":"Bogani","year":"2025","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.mtbio.2026.103121_bib72","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/1878-0261.12772","article-title":"Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms","volume":"15","author":"Friedenreich","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.mtbio.2026.103121_bib73","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00441-023-03831-0","article-title":"Exploration of eMSCs with HA-GEL system in repairing damaged endometrium after endometrial cancer with fertility-sparing treatment","volume":"394","author":"Liu","year":"2023","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.mtbio.2026.103121_bib74","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1186\/s12951-024-02780-2","article-title":"Thermosensitive hydrogel as a sustained release carrier for mesenchymal stem cell-derived extracellular vesicles in the treatment of intrauterine adhesion","volume":"22","author":"Yu","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.mtbio.2026.103121_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122923","article-title":"Ru single-atom nanozymes targeting ROS-ferroptosis pathways for enhanced endometrial regeneration in intrauterine adhesion therapy","volume":"315","author":"Liang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2026.103121_bib76","article-title":"3D printed gelatin\/PTMC core\/shell scaffolds with NIR laser-tuned drug\/biomolecule release for cancer therapy and uterine regeneration","volume":"283","author":"Chen","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mtbio.2026.103121_bib77","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3892\/or.2016.4888","article-title":"Effects of estradiol on VEGF and bFGF by Akt in endometrial cancer cells are mediated through the NF-\u03baB pathway","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.mtbio.2026.103121_bib78","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/s41416-021-01518-3","article-title":"Testosterone, sex hormone-binding globulin, insulin-like growth factor-1 and endometrial cancer risk: observational and Mendelian randomization analyses","volume":"125","author":"Mullee","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mtbio.2026.103121_bib79","article-title":"Therapeutic roles of platelet-rich plasma to restore female reproductive and endocrine dysfunction","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mtbio.2026.103121_bib80","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/13543784.2018.1558202","article-title":"Investigational PI3K\/AKT\/mTOR inhibitors in development for endometrial cancer","volume":"28","author":"Barra","year":"2019","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.mtbio.2026.103121_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122768","article-title":"Local delivery of platelet-derived factors mitigates ischemia and preserves ovarian function through angiogenic modulation: a personalized regenerative strategy for fertility preservation","volume":"313","author":"Chung","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2026.103121_bib82","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.2147\/IJN.S473259","article-title":"Advances in nanomedicine and biomaterials for endometrial regeneration: a comprehensive review","volume":"19","author":"Liu","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.mtbio.2026.103121_bib83","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1021\/acs.molpharmaceut.5c01062","article-title":"3D bioprinting and artificial intelligence for tumor microenvironment modeling: a scoping review of models, methods, and integration pathways","volume":"22","author":"Piotrowska","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mtbio.2026.103121_bib84","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10565-025-10064-0","article-title":"Advances in hybrid hydrogel design for biomedical applications: innovations in drug delivery and tissue engineering for gynecological cancers","volume":"41","author":"Chang","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.mtbio.2026.103121_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.101658","article-title":"Real-world treatment patterns and clinical outcomes in patients with advanced or recurrent endometrial cancer re-challenged with platinum-based chemotherapy in Europe","volume":"35","author":"Prabhu","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.mtbio.2026.103121_bib86","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ygyno.2025.02.013","article-title":"Platinum-free interval and response to platinum retreatment or lenvatinib\/pembrolizumab in patients with recurrent endometrial cancer: a real-world endometrial cancer molecularly targeted therapy consortium cohort study","volume":"194","author":"Haight","year":"2025","journal-title":"Gynecol. Oncol."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426003650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426003650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:39:53Z","timestamp":1790062793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426003650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":86,"alternative-id":["S2590006426003650"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103121","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomaterial-enabled multimodal therapy for endometrial cancer: Subtype-guided immuno-metabolic modulation and fertility-conscious regeneration","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103121"}}